Literature DB >> 23954601

Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.

Leonard L L Yeo1, Prakash Paliwal, Hock L Teoh, Raymond C Seet, Bernard P L Chan, Benjamin Wakerley, Shen Liang, Rahul Rathakrishnan, Vincent F Chong, Eric Y S Ting, Vijay K Sharma.   

Abstract

BACKGROUND: Intravenously administered tissue plasminogen activator (IV tPA) remains the only approved therapeutic agent for arterial recanalization in acute ischemic stroke (AIS). Considerable proportion of AIS patients demonstrate changes in their neurologic status within the first 24 hours of intravenous thrombolysis with IV tPA. However, there are little available data on the course of clinical recovery in subacute 2- to 24-hour window and its impact. We evaluated whether neurologic improvement at 2 and 24 hours after IV tPA bolus can predict functional outcomes in AIS patients at 3 months.
METHODS: Data for consecutive AIS patients treated with IV tPA within 4.5 hours of symptom onset during 2007-2011 were prospectively entered in our thrombolyzed registry. National Institutes of Health Stroke Scale (NIHSS) scores were recorded before IV tPA bolus, at 2 and 24 hours. Early neurologic improvement (ENI) at 2 hours was defined as a reduction in NIHSS score by 10 or more points from baseline or an absolute score of 4 or less points at 2 hours. Continuous neurologic improvement (CNI) was defined as a reduction of NIHSS score by 8 or more points between 2 and 24 hours or an absolute score of 4 or less points at 24 hours. Favorable functional outcomes at 3 months were determined by modified Rankin Scale (mRS) score of 0-1.
RESULTS: Of 2460 AIS patients admitted during the study period, 263 (10.7%) received IV tPA within the time window; median age was 64 years (range 19-92), with 63.9% being men, a median NIHSS score of 17 points (range 5-35), and a median onset-to-treatment time of 145 minutes (range 57-270). Overall, 130 (49.4%) thrombolyzed patients achieved an mRS score of 0-1 at 3 months. The female gender, age, and baseline NIHSS score were found to be significantly associated with CNI on univariate analysis. On multivariate analysis, NIHSS score at onset and female gender (odds ratio [OR]: 2.218, 95% confidence interval [CI]: 1.140-4.285; P=.024) were found to be independent predictors of CNI. Factors associated with favorable outcomes at 3 months on univariate analysis were younger age, female gender, hypertension, NIHSS score at onset, recanalization on transcranial Doppler (TCD) monitoring or repeat computed tomography (CT) angiography, ENI at 2 hours, and CNI. On multivariate analysis, NIHSS score at onset (OR per 1-point increase: .835, 95% CI: .751-.929, P<.001), 2-hour TCD recanalization (OR: 3.048, 95% CI: 1.537-6.046; P=.001), 24-hour CT angiographic recanalization (OR: 4.329, 95% CI: 2.382-9.974; P=.001), ENI at 2 hours (OR: 2.536, 95% CI: 1.321-5.102; P=.004), and CNI (OR: 7.253, 95% CI: 3.682-15.115; P<.001) were independent predictors of favorable outcomes at 3 months.
CONCLUSIONS: Women are twice as likely to have CNI from the 2- to 24-hour period after IV tPA. ENI and CNI within the first 24 hours are strong predictors of favorable functional outcomes in thrombolyzed AIS patients.
Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; early improvement; functional outcome; recovery; thrombolysis

Mesh:

Substances:

Year:  2013        PMID: 23954601     DOI: 10.1016/j.jstrokecerebrovasdis.2013.07.024

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  14 in total

1.  Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.

Authors:  Shashank Agarwal; Erica Scher; Aaron Lord; Jennifer Frontera; Koto Ishida; Jose Torres; Sara Rostanski; Eva Mistry; Brian Mac Grory; Shawna Cutting; Tina Burton; Brian Silver; Ava L Liberman; Mackenzie P Lerario; Karen Furie; James Grotta; Pooja Khatri; Jeffrey Saver; Shadi Yaghi
Journal:  Stroke       Date:  2020-02-27       Impact factor: 7.914

2.  The UCP2-866G/A Polymorphism Could be Considered as a Genetic Marker of Different Functional Prognosis in Ischemic Stroke After Recanalization.

Authors:  I Díaz-Maroto Cicuéndez; E Fernández-Díaz; J García-García; J Jordán; I Fernández-Cadenas; J Montaner; G Serrano-Heras; T Segura
Journal:  Neuromolecular Med       Date:  2017-10-17       Impact factor: 3.843

3.  Overlap in the Genetic Architecture of Stroke Risk, Early Neurological Changes, and Cardiovascular Risk Factors.

Authors:  Laura Ibanez; Laura Heitsch; Umber Dube; Fabiana H G Farias; John Budde; Kristy Bergmann; Rich Davenport; Joseph Bradley; Caty Carrera; Janne Kinnunen; Hanne Sallinen; Daniel Strbian; Agnieszka Slowik; Israel Fernandez-Cadenas; Joan Montaner; Jin-Moo Lee; Carlos Cruchaga
Journal:  Stroke       Date:  2019-05-14       Impact factor: 7.914

4.  Predictors of functional outcome in patients with stroke thrombolysis in a tertiary hospital in Malaysia.

Authors:  Mei-Ling Sharon Tai; Khean Jin Goh; Khairul Azmi Abdul Kadir; Mohd Idzwan Zakaria; Jun Fai Yap; Kay Sin Tan
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

5.  Clinical recovery and health-related quality of life in ischaemic stroke survivors receiving thrombolytic treatment: a 1-year follow-up study.

Authors:  Barbara Grabowska-Fudala; Krystyna Jaracz; Krystyna Górna; Jan Jaracz; Radosław Kaźmierski
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

6.  Implementation of Computerized Physician Order Entry Is Associated With Increased Thrombolytic Administration for Emergency Department Patients With Acute Ischemic Stroke.

Authors:  Dustin W Ballard; Anthony S Kim; Jie Huang; David K Park; Mamata V Kene; Uli K Chettipally; Hilary R Iskin; John Hsu; David R Vinson; Dustin G Mark; Mary E Reed
Journal:  Ann Emerg Med       Date:  2015-09-08       Impact factor: 5.721

7.  Racial Disparity in Stroke Awareness in the US: An Analysis of the 2014 National Health Interview Survey.

Authors:  Nwakile Ojike; Joe Ravenell; Azizi Seixas; Alina Masters-Israilov; April Rogers; Girardin Jean-Louis; Gbenga Ogedegbe; Samy I McFarlane
Journal:  J Neurol Neurophysiol       Date:  2016-04-07

Review 8.  Reperfusion therapy in acute ischemic stroke: dawn of a new era?

Authors:  Sonu Bhaskar; Peter Stanwell; Dennis Cordato; John Attia; Christopher Levi
Journal:  BMC Neurol       Date:  2018-01-16       Impact factor: 2.474

9.  Sex Differences in rt-PA Utilization at Hospitals Treating Stroke: The National Inpatient Sample.

Authors:  Amelia K Boehme; Brendan G Carr; Scott Eric Kasner; Karen C Albright; Michael J Kallan; Mitchell S V Elkind; Charles C Branas; Michael T Mullen
Journal:  Front Neurol       Date:  2017-09-27       Impact factor: 4.003

10.  Predictive values of CSS and NIHSS in the prognosis of patients with acute cerebral infarction: A comparative analysis.

Authors:  Xiao-Jing Zhao; Qun-Xi Li; Tie-Jun Liu; Da-Li Wang; Ya-Chen An; Jiang Zhang; Yan-Bo Peng; Rui-Ying Chen; Li-Sha Chang; Yan Wang; Li Zhang; Hai-Yan Fan; Xiu-Jie Wang; Fu-Xia Zheng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.